R&D Systems Human CXCL2/GRO beta/MIP-2/CINC-3 aa 35-107 Recombinant Protein
Manufacturer: R&D Systems 276GB010/CF
DescriptionMeasured by its ability to induce myeloperoxidase release from cytochalasin B-treated human neutrophils. Schröder, J.M. et al. (1987) J. Immunol. 139:3474. The ED 50 for this effect is 0.3-0.9 µg/mL. Measured by its ability to chemoattract BaF3 mouse pro-B cells transfected with human CXCR2. The ED 50 for this effect is 3-15 ng/mL.
|Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA.|
|97%, by SDS-PAGE under reducing conditions and visualized by silver stain.|
|CXCL2/GRO beta/MIP-2/CINC-3 aa 35-107|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|